The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats

Osteoporosis International

Volumn 8, Issue 3, 1998, Pages 274-281

  Fanti, P ^a   Monier Faugere, M C ^a   Geng, Z ^a   Schmidt, J ^a   Morris, P E ^a   Cohen, D ^a   Malluche, H H ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Isoflavones; Menopause; Metabolism; Osteoblast; Osteoclast; Soybean

Indexed keywords

CASEIN; CYTOKINE; DEOXYPYRIDINOLINE; GENISTEIN; OSTEOCALCIN; PHYTOESTROGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASIA; BONE ATROPHY; BONE MINERAL; CAUCASIAN; CONTROLLED STUDY; DIETARY INTAKE; INJECTION; MONONUCLEAR CELL; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE; URINARY EXCRETION; UTERUS;

AMINO ACIDS; ANIMALS; ATROPHY; BONE AND BONES; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENISTEIN; ORGAN SIZE; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 0031698560     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050065     Document Type: Article

References (39)

1. Maggi S, Kelsey JL, Litnak J, Heyse SP. Incidence of hip fractures in the elderly: a cross-national analysis. Osteoporos Int 1991; 1:232-241.
2. Ross PD, Fujiwara S, Huang C, Davis JW, Epstein RS. Wasnich RD et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasian or Japanese in the US. Int J Epidemiol 1995:24:1171-7.
3. Lau EMC, Cooper C. The epidemiology of osteoporosis: the oriental perspective in a world context. Clin Orthop 1996;323:65-74.
4. Holbrook TL, Barrett-Connor E, Wingard DL. Dietary calcium and risk of hip fracture: 14 year prospective population study. Lancet 1988 ;2:1046-9.
5. Hegsted DM. Calcium and osteoporosis. J Nutr 1986;116:2316-9.
6. Abelow BJ, Holford TR. Insogna KL. Cross-cultural association between dietary animal protein and hip fracture: a hypothesis. Calcif Tiss Int 1992:50:14-8
7. Adlercreutz H. Western diet and western disease: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;50 (Suppl 201):3-23.
8. Messina M. Modern applications of an ancient bean: soybeans and the prevention and treatment of chronic disease. J Nutr 1995; 125:567S-569S.
9. Sirtori CR, Lovati MR, Manzoni C. Monetti M, Pazzucconi F, Gatti E. Soy and cholesterol reduction: clinical experience. J Nutr 1995:125:5983-6055.
10. Adlercreutz H, Amalainen E, Gorbach S, Goldin B. Dietary phytoestrogens and the menopause in Japan. Lancet 1992; 339:1233.
11. Agnusdei D, Gennari C, Bufalino L. Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone active drug ipriflavone. Osteoporos Int 1995:5:462-6.
12. 3 in growing rats with skeletal unloading. Calcif Tissue Int 1996;58:88-94.
13. Arjmandi BH, Alekel L, Hollis BW, Amin D, StacewiczSapuntzakis M, Guo P, Kukreja SC Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996:126.161-7.
14. Franke AA, Custer LJ, Cerna CM. Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 1995:208:18-26.
15. Lieber CS. DeCarli LM. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res 1982:6:523-31
16. Fanti P. Kindy MS. Mohapatra S. Klein J, Colombo G, Malluche HH. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am J Physiol 1992;263:E1113-8.
17. Martens MFWC, van Hoek MJC. Wälchli R. Gamse R. Rosmalen FMA. The first radioimmunoassay to measure deoxypyridinoline in urine and serum. J Bone Miner Res 1994:9 (Suppl I):S335.
18. Malluche HH. Faugere M-C. Atlas of mineralized bone histology. Basel: S Karger, 1986.
19. Malluche HH, Sherman D. Meyer W, Massry SG. A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int 1982:34:439-48.
20. Parfitt AM. Drezner MK. Glorieux FH, Kanis JA. Malluche HH. Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987:6:595-610.
21. McClain C. Cohen D. Increased Tumor Necrosis Factor production by monocytes in alcoholic hepatitis. Hepatology 1989:9:349-51.
22. Kramer SM, Carver ME. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 1986; 93:201-6.
23. Omi N, Aoi S, Murata K, Ezawa I . Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. J Nutr Sci Vitaminol l994;40:201-11.
24. Allen LH, Oddoye EA, Margen S. Protein-induced hypercalciuria: a long term study. Am J Clin Nutr 1979:32:741-9.
25. Supko JG, Malspeis L. Plasma pharmacokinetics of genistein in mice. Int J Oncol 1995:7:847-54.
26. Farmakalidis E, Hancock JN, Murphy PA. Oestrogenic potency of genistein and daidzin in mice. Food Chem Toxicol 1985; 23:741-5.
27. Yang NN. Venugopalan M, Hardikar S. Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 1996; 273-1222-5.
28. Cheskis BJ. Karathanasis S, Lyttle CR. Estrogen receptor ligands modulate its interaction with DNA. J Biol Chem 1997; 272:11384-91.
29. Kuiper GGJM. Carlsson B. Grandien K. Enmark E. Haggblad J, Nilsson S. Gustafsson JA. Comparison of the ligand binding specificity, and transcription tissue distribution of estrogen receptors a and β. Endocrinology 138:863-870. 1997
30. Onoe Y, C Miyaura. H Ohta. S Nozawa. T Suda. Expression of estrogen receptor β in rat bone. Endocrinology 1997:138:4509-12.
31. Westerlind KC. Wakley GK, Evans GL. Turner RT. Estrogen does not increase bone formation in growing rats. Endocrinology 1993:133.2924-34.
32. Kalu DN, Liu CC, Salerno E, Hollis B, Echon R. Ray M. Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 1991;14:175-87.
33. Wronski TJ. Cintron M, Doherty AL. Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 1988:123:681-6.
34. Bertolini DR, Nedwin GE, Bringman TS. Smith DD. Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986:319:516-8.
35. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995; 136:3054-61.
36. Brandi ML. New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs. Am J Med 1993:95 (Suppl 5A):69S-74S.
37. Cheng S-L, Zhang SF, Nelson TL. Warlow PM. Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int 1994;55:356-62.
38. Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M. Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells. Calcif Tissue Int 1992:51:53-6.
39. Miksicek RJ. Estrogenic flavonoids: structural requirements for biologic activity. Proc Soc Exp Biol Med 1995:208:44-50.